Filter

Showing 1–12 of 258 results

+
 Quick View

Antibodies

5G12 Biosimilar – Research Grade [ICH5072]

$200.00 – $4,161.00
+
 Quick View

Antibodies

Abciximab Biosimilar – Research Grade [ICH5056]

$200.00 – $4,161.00
2020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$200.00 – $4,161.00
2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$200.00 – $2,601.00
+
 Quick View

anti-human

Aducanumab Biosimilar – Research Grade [ICH5008]

$200.00 – $4,161.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$200.00 – $2,601.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$200.00 – $4,161.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$200.00 – $4,161.00
+
 Quick View

Antibodies

Amatuximab Biosimilar – Research Grade [ICH5069]

$200.00 – $4,161.00
+
 Quick View

anti-mouse

Anti-CD115 In Vivo Antibody – Low Endotoxin (AFS98) [ICH1068]

$326.00 – $2,425.00
+
 Quick View

anti-mouse

Anti-CD11C In Vivo Antibody – Low Endotoxin (N418) [ICH1050]

$326.00 – $2,182.00
+
 Quick View

anti-human

Anti-CD151 In Vivo Antibody – Low Endotoxin (50-6) [ICH1019]

$320.00 – $2,140.00
View Cart Checkout Continue Shopping